Lixisenatide vs Oxyntomodulin

Head-to-head comparison of Lixisenatide (Exendin-4-derived GLP-1 receptor agonist) and Oxyntomodulin (Endogenous glucagon-like peptide 1 and glucagon co-agonist peptide) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyLixisenatideOxyntomodulin
CategoryWeight ManagementWeight Management
Full NameExendin-4-derived GLP-1 receptor agonistEndogenous glucagon-like peptide 1 and glucagon co-agonist peptide
Molecular Weight4858 Da~4,200 Da
Half-Life2-4 hours12-15 minutes
Amino Acids4437
Typical Dose10-20 mcg dailyResearch doses vary; commonly 100-300 mcg in small human studies
RouteSubcutaneousSubcutaneous/IV
Purity≥98%≥98%
Studies Count40080
Research StatusApprovedClinical

Lixisenatide Benefits

  • postprandial glucose control
  • modest weight loss
  • appetite reduction
  • short-acting option

Oxyntomodulin Benefits

  • reduces appetite
  • increases satiety
  • supports weight loss
  • improves postprandial metabolic signaling

Lixisenatide Dosing

10 mcg SC daily for 14 days|Increase to 20 mcg daily|Inject before the first meal of the day

Oxyntomodulin Dosing

Research-only dosing|Subcutaneous or IV administration in trials|Pair with calorie restriction and monitoring

Lixisenatide Side Effects

  • nausea
  • vomiting
  • hypoglycemia when combined with insulin

Oxyntomodulin Side Effects

  • nausea
  • GI discomfort
  • decreased appetite beyond target

Research Overview

Lixisenatide

Lixisenatide produces small but measurable weight loss in diabetes trials while improving postprandial glucose excursions. Its shorter half-life makes it a useful reference compound for first-generation incretin mimetics.

Oxyntomodulin

Human studies showed acute reductions in food intake and modest weight loss, helping establish the GLP-1 and glucagon co-agonism concept. It remains a foundational peptide for obesity and satiety research.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Lixisenatide stacks with:

basal-insulinmeal-plan

Oxyntomodulin stacks with:

calorie-deficitresistance-training
GLP-1RAshort-actingpostprandial-controlweight-loss-adjacentGLP-1glucagon-coagonistendogenous-peptideappetite-regulation